{
  "trial_id": "NCT00288600",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "drug does not yield the desired beneficial effects",
      "label": "met",
      "evidence": "none"
    },
    {
      "criterion": "An independent neonatologist will check the undesirable side effects and partially monitor the results of the study.",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Sample Size: The calculated size of the sample, considering a reduction of 30% on the indication of exchange transfusion, with a statistical significance of 95% and test power of 80% was 90 newborns.",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Randomization and blinding The randomization will be performed by drawing blocks of different sizes. In order to avoid that the health professionals in the nursery know which product is being infused into the newborns (Immunoglobulin or Saline Solution 0.9%) the syringes with the required volumes will be prepared in the pharmacy and wrapped in aluminum foil.",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Complementary treatment The complementary treatment will be administered and secured to all newborns admitted into the study and will follow the protocols below:",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Indication for phototherapy All newborns will receive phototherapy beginning in the first 6 hours of life The procedure adopted will be the triple phototherapy placed 50cms away from the newborns; the irradiance of the device will be measured every day.",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Indication for blood transfusion: The newborns that present the conditions mentioned below will be indicated to receive reed blood transfusion at the volume of 15ml/kg, according to criteria below:",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Auditory Evoked Potential All newborns involved in the study will undergo a non-invasive hearing test.",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "The patient is a 23-year-old man who came to the hospital with high blood pressure (175/95\u2009mmHg) and signs of septicemia. He developed respiratory failure requiring mechanical ventilation and renal failure requiring hemodialysis.",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "His blood smear showed microangiopathic hemolytic anemia and thrombocytopenia. His blood tests revealed elevated lactate dehydrogenase and reduced human complement C3 levels with a normal coagulation profile.",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "He was diagnosed with atypical hemolytic uremic syndrome. He was treated with plasma exchange and corticosteroids.",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "The genetic survey revealed ADAMTS13 >10%. ",
      "label": "unknown",
      "evidence": "none"
    }
  ],
  "exclusion": [
    {
      "criterion": "Newborns in serious condition, hydropic, hemodynamically instable or with indication for exchange transfusion at birth.",
      "label": "triggers",
      "evidence": "quote"
    },
    {
      "criterion": "The indications for exchange transfusion at birth are: presence of bilirubin in the umbilical cord higher or equal to 4mg%; hydrops, cardiac insufficiency secondary to severe anemia.",
      "label": "triggers",
      "evidence": "quote"
    }
  ],
  "notes": "Patient has high blood pressure and signs of septicemia. He developed respiratory failure requiring mechanical ventilation and renal failure requiring hemodialysis.",
  "_meta": {
    "topic_id": "68",
    "trial_id": "NCT00288600",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}